Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 997 results for "glaxo"

GSK and Genmab Announce Positive Interim Result for Phase III Study of Ofatumumab as Maintenance Therapy for Relapsed CLL

Positive interim results for ofatumumab

In a Phase 3 study evaluating the safety and efficacy of GlaxoSmithKline ( GSK -0.1% ) and Genmab's ofatumumab for the treatment of patients with relapsed chronic lymphocytic leukemia who responded to treatment at relapse, an independent Data ... Seeking Alpha, 2 hours ago

1,188 images for glaxo, 2 days ago
American Banking News, 1 day ago
Chicago Tribune, 2 days ago
Hartford Courant, 2 days ago
Citywire, 13 hours ago
Irish Independent, 2 days ago, 2 days ago
Voice of America, 1 day ago
Voice of America, 1 day ago
Reuters UK, 2 days ago

GlaxoSmithKline Q2 profit down

GlaxoSmithKline plc, or GSK, has reported that profit attributable to shareholders for the second quarter ended June 30, 2014, was GBP654 million, or 13.4 pence per diluted share, compared to GBP1.04 billion, or 21.2 pence per diluted share, for the ...
 Individual.com10 hours ago diaDexus Posts 2nd Quarter 2014 Financial Results  Individual.com17 hours ago Theravance to Report Second Quarter 2014 Financial Results on August 6, 2014  CEOWorld Magazine2 days ago Seattle Genetics Reports Second Quarter 2014 Financial Results  Fat Pitch Financials1 hour ago

GlaxoSmithKline plc And Reckitt Benckiser plc Aim To Unlock Value

The pharma sector is in upheaval, with massive deals making weekly headlines and companies taking evasive action to pre-empt the advances of predators. But will separating drugs businesses from consumer healthcare divisions reallyreap dividends for ...
 Motley Fool UK7 hours ago
Bio Spectrum Asia

Public Chinese trial for GSK-tied investigators

Singapore: The Chinese government has now officially announced that the trial of the two private investigators tied to GlaxoSmithKline's operations in the country will be held on August 8. A Chinese court revealed that the duo would be in court ...
 Bio Spectrum Asia13 hours ago China sets trial date for GSK-tied investigators says it will be open  Big News Network2 days ago

HINT: 'We will never own GlaxoSmithKline'

In this video interview we hear from Ben Lofthouse , manager ofthe Henderson International Income ( HINT ) investment trust, which was recently positively reviewed by Citywire columnist James Carthew. HINTis the only trust in its Global Growth & ...
 Citywire13 hours ago

GlaxoSmithKline's Breo Ellipta early signs indicate somewhat sluggish uptake in the US market

It remains early in the launch, but available evidence suggests that GlaxoSmithKline's Breo Ellipta the first marketed ICS/LABA therapy for chronic obstructive pulmonary disease (COPD) that is administered once daily is experiencing somewhat ...
 TransWorldNews16 hours ago

GlaxoSmithKline faced a challenging Q1 in the US respiratory segment despite its market-leading position

Set against the backdrop of a streamlined therapeutic focus, in the asthma and chronic obstructive pulmonary disease (COPD) fields. Streamlined and refocused, but GlaxoSmithKline needs respiratory portfolio to deliver. Quarterly sales of its ...
 TransWorldNews17 hours ago Chronic obstructive pulmonary disorder market valued at US$10Bn in 2013  TransWorldNews16 hours ago

Company also gives RM10,000 to home for Hari Raya

CHILDREN from Rumah Bakti Dato Harun greeted Hari Raya Aidilfitri in new clothes thanks to GlaxoSmithKline (GSK) Consumer Healthcare. The company recently took 27 children from the home to Mydin Hypermarket USJ to shop for baju raya. The ... hours ago

Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine

PUBLIC RELEASE DATE: 31-Jul-2014 A long-term follow-up study (HPV-023; NCT00518336) shows the sustained efficacy, immunogenicity and safety of GlaxoSmithKline's human papilloma virus (HPV) vaccine Cervarix. Women vaccinated with the HPV-16/18 ...
 EurekAlert!2 hours ago The current HPV vaccines market is dominated by one major player, Merck's Gardasil, with GlaxoSmithKline's (GSK's) HPV vaccine Cervarix providing the only competition  TransWorldNews2 days ago
Finance 24

GlaxoSmithKline dividend safe for now

London - GlaxoSmithKline's fat dividend is under strain but Britain's biggest drugmaker is likely to scrape by without cutting payouts as it seeks to compensate investors during a bumpy reshaping of the company. Worries about GSK's dividend, which ...
 Finance 241 day ago Despite strains, GlaxoSmithKline dividend seen safe for now  Reuters UK2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less